Gene Patents Would Be Limited Under HHS Advisory Panel Proposal
This article was originally published in The Gray Sheet
Executive Summary
An HHS advisory committee is proposing that anyone who uses a gene patent to make or sell a diagnostic test or for research purposes should not be liable for infringement